Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma

Clinical trial NCT05201326 · UNKNOWN

Trial details

NCT number: NCT05201326
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2021-12-22
Primary completion: 2022-12-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.